Sarepta Therapeutics (SRPT) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.96% |
| Dec 31, 2025 | 8.41% |
| Sep 30, 2025 | 8.15% |
| Jun 30, 2025 | 5.41% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | 13.30% |
| Sep 30, 2024 | 4.18% |
| Jun 30, 2024 | -0.41% |
| Mar 31, 2024 | -6.55% |
| Dec 31, 2023 | -3.60% |
| Sep 30, 2023 | 3.62% |
| Jun 30, 2023 | 1.18% |
| Mar 31, 2023 | -1.71% |
| Dec 31, 2022 | -13.38% |
| Sep 30, 2022 | -9.18% |
| Jun 30, 2022 | 13.97% |
| Mar 31, 2022 | 14.83% |
| Dec 31, 2021 | 22.48% |
| Sep 30, 2021 | 2.82% |
| Jun 30, 2021 | 31.91% |
| Mar 31, 2021 | 30.97% |
| Dec 31, 2020 | 31.96% |
| Sep 30, 2020 | 48.57% |
| Jun 30, 2020 | 44.53% |
| Mar 31, 2020 | 41.65% |
| Dec 31, 2019 | 27.00% |
| Sep 30, 2019 | 28.31% |
| Jun 30, 2019 | 29.66% |
| Mar 31, 2019 | 42.57% |
| Dec 31, 2018 | 33.09% |
| Sep 30, 2018 | 20.97% |
| Jun 30, 2018 | 51.08% |
| Mar 31, 2018 | 54.84% |
| Dec 31, 2017 | 44.87% |
| Mar 31, 2017 | 98.22% |
| Dec 31, 2016 | 61.11% |
| Sep 30, 2016 | 66.69% |
| Jun 30, 2016 | 28.15% |
| Dec 31, 2015 | 133.61% |